Quarter 2026/Q2
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| Deferred Tax | -$14.80M | -$17.60M | $7.60M | -$28.40M | $8.20M |
| Net Other Financing Charges | -$7.10M | -$9.60M | -$38.80M | -$135.00M | -$298.10M |
| Ending Cash Balance | $246.20M | $173.40M | $227.20M | $230.70M | $101.20M |
| Net Change in Cash | $56.10M | -$41.80M | -$7.30M | $149.70M | -$36.90M |
| Beginning Cash Balance | $173.40M | $227.20M | $230.70M | $101.20M | $145.10M |
| Effect of Exchange Rate Changes | $16.70M | -$12.00M | $3.80M | -$20.20M | -$7.00M |
| Free Cash Flow | $198.30M | $168.70M | $245.20M | $284.70M | $258.40M |
| Net Income from Continuing Operations | $145.10M | $184.10M | $188.30M | $204.90M | $178.00M |
| Net cash flow from continuing operations | $241.50M | $214.10M | $276.30M | $306.00M | $277.00M |
| Operating Cash Flow | $241.50M | $214.10M | $276.30M | $306.00M | $277.00M |
| Financing Cash Flow | $363.60M | $62.10M | -$252.50M | -$135.00M | -$298.10M |
| Net Investment Purchase and Sale | -$116.50M | $0.00 | $0.00 | $0.00 | – |
| Cash Dividends Paid | -$39.00M | -$36.60M | -$23.70M | $0.00 | $0.00 |
| Proceeds from Stock Option Exercised | $2.60M | $3.30M | $5.00M | $0.00 | $0.00 |
| Gain/Loss from Continuing Operations | $6.00M | $100,000.00 | -$1.10M | -$300,000.00 | -$1.20M |
| Net Issuance Payments Of Debt | $407.10M | $105.00M | -$195.00M | $0.00 | $0.00 |
| Other Non-Cash Items | $2.90M | $700,000.00 | -$6.40M | $2.50M | -$4.50M |
| Change in Working Capital | -$17.00M | -$50.60M | $0.00 | $39.30M | $6.10M |
| -Change in Receivables | -$46.80M | -$44.40M | -$6.30M | $300,000.00 | -$22.20M |
| -Change in Inventory | $5.20M | $21.30M | -$1.00M | -$12.70M | $9.30M |
| -Change in Payables and Accrued Expense | $41.00M | -$18.50M | $7.30M | $52.30M | $33.70M |
| -Change in Other Current Assets | -$16.40M | -$9.00M | $0.00 | -$600,000.00 | -$14.70M |
| Net cash flow from investing | -$549.00M | -$318.00M | -$31.10M | -$21.30M | -$15.80M |
| Net Cash Flow from Continuing Investing Activities | -$549.00M | -$318.00M | -$31.10M | -$21.30M | -$15.80M |
| Capital Expenditure | -$43.20M | -$45.40M | -$31.10M | -$21.30M | -$18.60M |
| Net Business Purchase and Sale | -$391.10M | -$269.90M | $0.00 | $0.00 | – |
| Net Other Investing Changes | $1.80M | -$2.70M | – | – | – |
| Depreciation & Depletion & Amortization | $106.60M | $86.80M | $77.60M | $78.70M | $81.80M |
| Net Cash Flow from Continuing Financing Activities | $363.60M | $62.10M | -$252.50M | -$135.00M | -$298.10M |
| Net PPE Purchase and Sale | – | – | – | – | $2.80M |
No comments yet — be the first to weigh in on CXT.